Market closedNon-fractional

Scholar Rock/SRRK

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Scholar Rock

Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia. Geographically, the company operates in the United States. The company's product candidate is Apitegroma which is a selective, fully human, monoclonal antibody, with a mechanism of action that results in inhibition of the activation of the growth factor, myostatin, in skeletal muscle. Its other product comprises SRK-181, an inhibitor of the activation of latent transforming growth factor beta-1 ("TGFβ1"), for the treatment of cancers that are resistant to anti-PD-(L)1 antibody therapies.

Ticker

SRRK

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Cambridge, United States

Employees

150

Scholar Rock Metrics

BasicAdvanced
$620M
Market cap
-
P/E ratio
-$2.30
EPS
0.94
Beta
-
Dividend rate
$620M
0.94
6.584
6.387
25.718
32.897
-29.11%
-40.64%
-89.09%
3.38
3.38
-4.076
-2.84%
-8.42%

What the Analysts think about Scholar Rock

Analyst Ratings

Majority rating from 9 analysts.
Buy

Scholar Rock Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$57M
23.21%
Profit margin
0.00%
NaN%

Scholar Rock Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 15.86%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.47
-$0.53
-$0.50
-$0.59
-
Expected
-$0.56
-$0.52
-$0.49
-$0.51
-$0.61
Surprise
-15.36%
1.75%
2.56%
15.86%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Scholar Rock stock?

Scholar Rock (SRRK) has a market cap of $620M as of July 05, 2024.

What is the P/E ratio for Scholar Rock stock?

The price to earnings (P/E) ratio for Scholar Rock (SRRK) stock is 0 as of July 05, 2024.

Does Scholar Rock stock pay dividends?

No, Scholar Rock (SRRK) stock does not pay dividends to its shareholders as of July 05, 2024.

When is the next Scholar Rock dividend payment date?

Scholar Rock (SRRK) stock does not pay dividends to its shareholders.

What is the beta indicator for Scholar Rock?

Scholar Rock (SRRK) has a beta rating of 0.94. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Scholar Rock stock

Buy or sell Scholar Rock stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing